10-71712805-A-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM1BP4_StrongBP6
The NM_022124.6(CDH23):c.3361A>T(p.Ile1121Phe) variant causes a missense change. The variant allele was found at a frequency of 0.000238 in 1,612,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00013 ( 0 hom. )
Consequence
CDH23
NM_022124.6 missense
NM_022124.6 missense
Scores
1
11
5
Clinical Significance
Conservation
PhyloP100: 6.27
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
C10orf105 (HGNC:20304): (chromosome 10 open reading frame 105) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM1
In a domain Cadherin 11 (size 105) in uniprot entity CAD23_HUMAN there are 5 pathogenic changes around while only 2 benign (71%) in NM_022124.6
BP4
Computational evidence support a benign effect (MetaRNN=0.013111502).
BP6
Variant 10-71712805-A-T is Benign according to our data. Variant chr10-71712805-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 45916.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3, Benign=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.3361A>T | p.Ile1121Phe | missense_variant | 28/70 | ENST00000224721.12 | NP_071407.4 | |
C10orf105 | NM_001164375.3 | c.*3131T>A | 3_prime_UTR_variant | 2/2 | ENST00000441508.4 | NP_001157847.1 | ||
CDH23 | NM_001171930.2 | c.3361A>T | p.Ile1121Phe | missense_variant | 28/32 | NP_001165401.1 | ||
C10orf105 | NM_001168390.2 | c.*3131T>A | 3_prime_UTR_variant | 2/2 | NP_001161862.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDH23 | ENST00000224721.12 | c.3361A>T | p.Ile1121Phe | missense_variant | 28/70 | 5 | NM_022124.6 | ENSP00000224721.9 | ||
C10orf105 | ENST00000441508.4 | c.*3131T>A | 3_prime_UTR_variant | 2/2 | 1 | NM_001164375.3 | ENSP00000403151.2 |
Frequencies
GnomAD3 genomes AF: 0.00127 AC: 193AN: 152256Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
193
AN:
152256
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000332 AC: 81AN: 243680Hom.: 0 AF XY: 0.000218 AC XY: 29AN XY: 132766
GnomAD3 exomes
AF:
AC:
81
AN:
243680
Hom.:
AF XY:
AC XY:
29
AN XY:
132766
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000129 AC: 188AN: 1459744Hom.: 0 Cov.: 31 AF XY: 0.000125 AC XY: 91AN XY: 725998
GnomAD4 exome
AF:
AC:
188
AN:
1459744
Hom.:
Cov.:
31
AF XY:
AC XY:
91
AN XY:
725998
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00129 AC: 196AN: 152374Hom.: 0 Cov.: 33 AF XY: 0.00125 AC XY: 93AN XY: 74522
GnomAD4 genome
AF:
AC:
196
AN:
152374
Hom.:
Cov.:
33
AF XY:
AC XY:
93
AN XY:
74522
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
17
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
48
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:2Benign:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Feb 21, 2017 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Sep 05, 2017 | The p.Ile1121Phe variant (rs200542052) has not been reported in the medical literature. This variant is listed in the Genome Aggregation Database (gnomAD) browser with an allele frequency of 0.46% in the African population (identified in 108 out of 23,580 chromosomes; 0 homozygotes), and is listed in ClinVar with conflicting interpretations of pathogenicity (benign/uncertain significance; Variant ID: 45916). The isoleucine at codon 1121 is highly conserved considering 12 species up to zebrafish (Alamut software v2.9.0), and computational analyses suggest that this variant affects the CDH23 protein structure/function (SIFT: damaging, PolyPhen2: possibly damaging, MutationTaster: disease causing). While the frequency of this variant in the African population suggests that it is a benign polymorphism, the available evidence is insufficient to classify the clinical significance with certainty. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2020 | - - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Mar 20, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 02, 2015 | p.Ile1121Phe in exon 28 of CDH23: This variant is not expected to have clinical significance because it is has been identified in 0.6% (44/7874) of African chro mosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.or g; dbSNP rs200542052). - |
Usher syndrome type 1 Benign:1
Likely benign, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 13, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;.;L;.;.
PrimateAI
Uncertain
T
REVEL
Uncertain
Sift4G
Uncertain
D;D;.;D;.
Polyphen
0.85
.;.;P;.;.
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at